Spinelab AG

SpineLab and Precimed announce strategic partnership

    Winterthur/Switzerland (ots) - SpineLab AG, a privately held company, specialized in developing a dynamic stabilization system for the spine, announced today the strategic partnership with Precimed Group, a leading technology-driven supplier to the orthopaedic industry.

    Under this agreement, Precimed co-develops the minimally invasive instrument set and will exclusively handle production and logistics for SpineLab's dynamic stabilization system DynaSpine(tm). SpineLab will benefit from Precimed's state-of-the-art development and manufacturing facilities as well as from their network with the orthopaedic industry.

    "This partnership allows SpineLab to focus on selected key areas like clinical results, intellectual property and regulatory approvals. SpineLab will benefit from the domain expertise and international infrastructure of Precimed." said Thomas Zehnder, President & CEO of SpineLab.

    "Dynamic stabilization for the spine is one of the fastest growing market segments in the orthopaedic industry and we believe SpineLab's product will offer some unique clinical benefits to patients. This strategic partnership is a great business model to develop Precimed into a full-service system provider even for large orthopaedic companies." says Patrick Berdoz, Chairman and CEO of Precimed Group.

    About SpineLab

    SpineLab AG is developing a second generation Dynamic Stabilization System for the spine: DynaSpine™. The system is unique in having a simple approach to establish consistent biomechanical conditions. SpineLab's patents cover a wide range of design options including minimally invasive approaches. www.spinelab.com

    About Precimed

    Precimed is a growing Swiss medtech company focusing on the design and development of innovative instruments, trays and cases for the orthopaedic industry. The company has its global headquarters in Orvin, Switzerland, North American headquarters in Exton, PA near Philadelphia as well as subsidiaries in the United Kingdom, Japan and China. Manufacturing facilities are located throughout Switzerland and in the US. Precimed employs over 445 highly qualified employees. www.precimed.com

ots Originaltext: SpineLab AG
Internet: www.presseportal.ch

Dr. Thomas Zehnder
President & CEO, SpineLab AG
Phone:  +41/52-204-03-34
E-Mail: thomas.zehnder@spinelab.com

Barbara Lyons
Director of Global Marketing, Precimed Group
Phone:  +1-610-524-83-00
E-Mail: b.lyons@precimed.com

Weitere Meldungen: Spinelab AG

Das könnte Sie auch interessieren: